Analysis of The Budget Impact of Secukinumab use Versus Anti-Tnf Agents in Ankylosing Spondylitis Patients
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.2969
https://www.valueinhealthjournal.com/article/S1098-3015(17)33303-X/fulltext
Section Title :
Disease-Specific Studies
Section Order :
2717
First Page :
A937
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)33303-X&doi=10.1016/j.jval.2017.08.2969